Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989;82(Suppl 17):63–68.

Antimalarial drugs currently in development.

W E Gutteridge 1
PMCID: PMC1291944  PMID: 2693729

Full text

PDF
63

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carvalho L. H., Rocha E. M., Raslan D. S., Oliveira A. B., Krettli A. U. In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum. Braz J Med Biol Res. 1988;21(3):485–487. [PubMed] [Google Scholar]
  2. Gottesman M. M., Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem. 1988 Sep 5;263(25):12163–12166. [PubMed] [Google Scholar]
  3. Gutteridge W. E. New anti-protozoal agents. Int J Parasitol. 1987 Feb;17(1):121–129. doi: 10.1016/0020-7519(87)90033-6. [DOI] [PubMed] [Google Scholar]
  4. Horton R. J. Introduction of halofantrine for malaria treatment. Parasitol Today. 1988 Sep;4(9):238–239. doi: 10.1016/0169-4758(88)90136-6. [DOI] [PubMed] [Google Scholar]
  5. Li J., Huang W. J. [Effects of artesunate, pyronaridine and hydroxypiperaquine on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum in vitro]. Zhongguo Yao Li Xue Bao. 1988 Jan;9(1):83–86. [PubMed] [Google Scholar]
  6. Makinde J. M., Amusan O. O., Adesogan E. K. The antimalarial activity of Spathodea campanulata stem bark extract on Plasmodium berghei berghei in mice. Planta Med. 1988 Apr;54(2):122–125. doi: 10.1055/s-2006-962367. [DOI] [PubMed] [Google Scholar]
  7. Martin S. K., Oduola A. M., Milhous W. K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 1987 Feb 20;235(4791):899–901. doi: 10.1126/science.3544220. [DOI] [PubMed] [Google Scholar]
  8. Midgley J. M., Keter D. W., Phillipson J. D., Grant S., Warhurst D. C. Quinolones and multiresistant Plasmodium falciparum. Lancet. 1988 Jul 30;2(8605):281–281. doi: 10.1016/s0140-6736(88)92571-8. [DOI] [PubMed] [Google Scholar]
  9. Pang L., Limsomwong N., Singharaj P. Prophylactic treatment of vivax and falciparum malaria with low-dose doxycycline. J Infect Dis. 1988 Nov;158(5):1124–1127. doi: 10.1093/infdis/158.5.1124. [DOI] [PubMed] [Google Scholar]
  10. Panton L. J., Rossan R. N., Escajadillo A., Matsumoto Y., Lee A. T., Labroo V. M., Kirk K. L., Cohen L. A., Aikawa M., Howard R. J. In vitro and in vivo studies of the effects of halogenated histidine analogs on Plasmodium falciparum. Antimicrob Agents Chemother. 1988 Nov;32(11):1655–1659. doi: 10.1128/aac.32.11.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Scott H. V., Tan W. L., Barlin G. B. The in vitro and in vivo antimalarial activity of some Mannich bases derived from 4-[7'-bromo (and chloro)-1',5'-naphthyridin-4'-ylamino]phenol and 4-(7'-trifluoromethylquinolin-4'-ylamino)phenol. Ann Trop Med Parasitol. 1988 Apr;82(2):127–134. doi: 10.1080/00034983.1988.11812219. [DOI] [PubMed] [Google Scholar]
  12. Zhang Y. A., Hempelmann E., Schirmer R. H. Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem Pharmacol. 1988 Mar 1;37(5):855–860. doi: 10.1016/0006-2952(88)90172-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES